Davidson Zhao

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Detection and classification of lymphoma from cell-free methylome data.

Detection and classification of lymphoma from cell-free methylome data.

Journal: NPJ precision oncology

Published: August 26, 2025

Risk Assessment With Ultra-Low-Pass Whole-Genome Sequencing of Cell-Free DNA for Large B-Cell Lymphoma.

Risk Assessment With Ultra-Low-Pass Whole-Genome Sequencing of Cell-Free DNA for Large B-Cell Lymphoma.

Journal: JCO precision oncology

Published: July 09, 2025

Genetic Landscape and Risk Stratification of AML With Hyperdiploid Karyotype.

Genetic Landscape and Risk Stratification of AML With Hyperdiploid Karyotype.

Journal: European journal of haematology

Published: March 25, 2025

Proposed Refinement of 2022 European LeukemiaNet Adverse-Risk Group of AML Patients Using a Real-World Cohort.

Proposed Refinement of 2022 European LeukemiaNet Adverse-Risk Group of AML Patients Using a Real-World Cohort.

Journal: Cancers

Published: March 05, 2025

Molecular genetic characterization of mixed-phenotype acute leukemia (MPAL) with BCR::ABL1 fusion.

Molecular genetic characterization of mixed-phenotype acute leukemia (MPAL) with BCR::ABL1 fusion.

Journal: Leukemia research

Published: December 27, 2024

Impact of secondary-type mutations in acute myeloid leukemia with CEBPA mutation.

Impact of secondary-type mutations in acute myeloid leukemia with CEBPA mutation.

Journal: EJHaem

Published: October 31, 2024

A real-world analysis of clinical outcomes in AML with myelodysplasia-related changes: a comparison of ICC and WHO-HAEM5 criteria.

A real-world analysis of clinical outcomes in AML with myelodysplasia-related changes: a comparison of ICC and WHO-HAEM5 criteria.

Journal: Blood advances

Published: October 06, 2023

AML with CEBPA mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blasts.

AML with CEBPA mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blasts.

Journal: Leukemia research

Published: July 13, 2023

TP53 Mutations in AML Patients Are Associated with Dismal Clinical Outcome Irrespective of Frontline Induction Regimen and Allogeneic Hematopoietic Cell Transplantation.

TP53 Mutations in AML Patients Are Associated with Dismal Clinical Outcome Irrespective of Frontline Induction Regimen and Allogeneic Hematopoietic Cell Transplantation.

Journal: Cancers

Published: May 02, 2023

Impact of secondary-type mutations in NPM1 mutated AML.

Impact of secondary-type mutations in NPM1 mutated AML.

Journal: European journal of haematology

Published: January 23, 2023

Molecular genetic characterization of Philadelphia chromosome-positive acute myeloid leukemia.

Molecular genetic characterization of Philadelphia chromosome-positive acute myeloid leukemia.

Journal: Leukemia research

Published: November 06, 2022

Differences in in-hospital outcomes and healthcare utilization for laparoscopic versus open approach for emergency inguinal hernia repair: a nationwide analysis.

Differences in in-hospital outcomes and healthcare utilization for laparoscopic versus open approach for emergency inguinal hernia repair: a nationwide analysis.

Journal: Hernia : the journal of hernias and abdominal wall surgery

Published: October 26, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026